Teladoc Health, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Director or officer changeSep 25 →Insiders1 insider bought $69,400 in 1 open-market buy. 6 insiders sold $1.9M, 5 of 24 sales on a 10b5-1 plan.→HoldersBlackRock 8.9%Vanguard Portfolio 7.0%Point72 4.5%→PeersClosest companies: AMWL, VSEE, OMDA→
From the filings
Figures
- Revenue
- $2.49Blast 12 months
- Net income
- −$177.4Mlast 12 months
- Operating cash flow
- $288.0Mlast 12 months
- Cash and equivalents
- $774.3Mat the last balance sheet
- Shares outstanding
- 181.6M shareson issue